Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE)

SB 251 requires specific health insurance plans - including those offered by state/local governments - to cover asthma prescription drugs and related medical supplies (like inhalers) without deductibles. It caps patient out-of-pocket costs at $25 per month for asthma medications and $50 per month for related supplies, preventing higher costs as treatment needs increase. This applies to limited service health organizations, preferred provider plans, and defined network plans covering asthma treatment. The bill takes effect for new policy years starting after its enactment, ensuring consistent affordability for covered asthma care.